Atopic dermatitis (eczema) trials in Greece

1 of 1 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

  Where

  Athens, Chaïdári, Efkarpia, Ioannina, Thessaloniki

  Age

  12 years and over

  People

  510 worldwide

  Run by

  Nektar Therapeutics

  See details and how to joinNCT07690371 · EU 2025-524925-42-00